JPS59193814A - アミノ酸含有脂肪乳剤 - Google Patents

アミノ酸含有脂肪乳剤

Info

Publication number: JPS59193814A
Authority: JP; Japan
Prior art keywords: fat; amino acid; fat emulsion; emulsion; range
Prior art date: 1983-04-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP58069712A

Other languages

English (en)

Japanese (ja)

Other versions

JPH0463049B2 (2

Inventor

Hiroyuki Ohashi

弘幸大橋

Toshiaki Hattori

服部　俊昭

Tetsuo Kobayashi

哲男小林

Shigefumi Hashimoto

重文橋本

Toru Takami

徹高見

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ajinomoto Co Inc

Original Assignee

Ajinomoto Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-04-20

Filing date

1983-04-20

Publication date

1984-11-02

1983-04-20 Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc

1983-04-20 Priority to JP58069712A priority Critical patent/JPS59193814A/ja

1984-03-22 Priority to ZA842129A priority patent/ZA842129B/xx

1984-04-18 Priority to EP19840901610 priority patent/EP0144434A4/en

1984-04-18 Priority to CA000452321A priority patent/CA1217725A/en

1984-04-18 Priority to PCT/JP1984/000196 priority patent/WO1984004244A1/ja

1984-04-20 Priority to IT20670/84A priority patent/IT1176120B/it

1984-04-20 Priority to KR1019840002093A priority patent/KR910002637B1/ko

1984-11-02 Publication of JPS59193814A publication Critical patent/JPS59193814A/ja

1992-10-08 Publication of JPH0463049B2 publication Critical patent/JPH0463049B2/ja

Status Granted legal-status Critical Current

Links

150000001413 amino acids Chemical class 0.000 title claims abstract description 31
239000002960 lipid emulsion Substances 0.000 title claims abstract description 13
239000002253 acid Substances 0.000 claims description 14
239000000839 emulsion Substances 0.000 claims description 8
235000014633 carbohydrates Nutrition 0.000 claims description 5
150000001720 carbohydrates Chemical class 0.000 claims description 5
239000003795 chemical substances by application Substances 0.000 claims description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
239000000600 sorbitol Substances 0.000 claims description 2
235000003913 Coccoloba uvifera Nutrition 0.000 claims 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
235000011511 Diospyros Nutrition 0.000 claims 1
244000236655 Diospyros kaki Species 0.000 claims 1
101100452374 Mus musculus Ikbke gene Proteins 0.000 claims 1
240000007594 Oryza sativa Species 0.000 claims 1
235000007164 Oryza sativa Nutrition 0.000 claims 1
240000008976 Pterocarpus marsupium Species 0.000 claims 1
150000001412 amines Chemical class 0.000 claims 1
235000013339 cereals Nutrition 0.000 claims 1
230000002641 glycemic effect Effects 0.000 claims 1
150000004677 hydrates Chemical class 0.000 claims 1
235000009566 rice Nutrition 0.000 claims 1
102220005637 rs25409 Human genes 0.000 claims 1
150000003839 salts Chemical class 0.000 claims 1
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
-1 organic acid salt Chemical class 0.000 abstract description 6
239000004472 Lysine Substances 0.000 abstract description 4
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract description 4
230000007774 longterm Effects 0.000 abstract description 3
239000002245 particle Substances 0.000 abstract description 3
230000001954 sterilising effect Effects 0.000 abstract description 2
235000001014 amino acid Nutrition 0.000 abstract 5
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 abstract 2
RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 abstract 2
235000013477 citrulline Nutrition 0.000 abstract 2
229960002173 citrulline Drugs 0.000 abstract 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
239000004471 Glycine Substances 0.000 abstract 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
239000004473 Threonine Substances 0.000 abstract 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
235000004279 alanine Nutrition 0.000 abstract 1
238000010253 intravenous injection Methods 0.000 abstract 1
239000004474 valine Substances 0.000 abstract 1
239000003925 fat Substances 0.000 description 15
235000019197 fats Nutrition 0.000 description 15
238000001802 infusion Methods 0.000 description 9
238000000034 method Methods 0.000 description 5
239000011574 phosphorus Substances 0.000 description 5
229910052698 phosphorus Inorganic materials 0.000 description 5
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
230000000052 comparative effect Effects 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
210000002969 egg yolk Anatomy 0.000 description 3
239000003797 essential amino acid Substances 0.000 description 3
235000020776 essential amino acid Nutrition 0.000 description 3
239000011347 resin Substances 0.000 description 3
229920005989 resin Polymers 0.000 description 3
210000003462 vein Anatomy 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000283153 Cetacea Species 0.000 description 2
102000002322 Egg Proteins Human genes 0.000 description 2
108010000912 Egg Proteins Proteins 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
235000013345 egg yolk Nutrition 0.000 description 2
230000001804 emulsifying effect Effects 0.000 description 2
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
229960003646 lysine Drugs 0.000 description 2
239000000203 mixture Substances 0.000 description 2
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
235000003441 saturated fatty acids Nutrition 0.000 description 2
150000004671 saturated fatty acids Chemical class 0.000 description 2
239000000126 substance Substances 0.000 description 2
OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
241001320911 Anorus Species 0.000 description 1
235000017060 Arachis glabrata Nutrition 0.000 description 1
244000105624 Arachis hypogaea Species 0.000 description 1
235000010777 Arachis hypogaea Nutrition 0.000 description 1
235000018262 Arachis monticola Nutrition 0.000 description 1
240000002791 Brassica napus Species 0.000 description 1
235000011293 Brassica napus Nutrition 0.000 description 1
235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
241000134884 Ericales Species 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
125000000773 L-serino group Chemical group [H]OC(=O)[C@@]([H])(N([H])*)C([H])([H])O[H] 0.000 description 1
239000005642 Oleic acid Substances 0.000 description 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
235000021314 Palmitic acid Nutrition 0.000 description 1
235000003434 Sesamum indicum Nutrition 0.000 description 1
244000000231 Sesamum indicum Species 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
238000002679 ablation Methods 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
210000001268 chyle Anatomy 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
239000002385 cottonseed oil Substances 0.000 description 1
WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
KSCFJBIXMNOVSH-UHFFFAOYSA-N dyphylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)CO)C=N2 KSCFJBIXMNOVSH-UHFFFAOYSA-N 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
230000000694 effects Effects 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
238000004945 emulsification Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
239000003292 glue Substances 0.000 description 1
230000009545 invasion Effects 0.000 description 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229960005337 lysine hydrochloride Drugs 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
235000020232 peanut Nutrition 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
230000002265 prevention Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000001698 pyrogenic effect Effects 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
239000000243 solution Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
150000005846 sugar alcohols Chemical class 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
230000014616 translation Effects 0.000 description 1
235000021122 unsaturated fatty acids Nutrition 0.000 description 1
150000004670 unsaturated fatty acids Chemical class 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Dispersion Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Cosmetics (AREA)

JP58069712A 1983-04-20 1983-04-20 アミノ酸含有脂肪乳剤 Granted JPS59193814A (ja)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
JP58069712A JPS59193814A (ja)	1983-04-20	1983-04-20	アミノ酸含有脂肪乳剤
ZA842129A ZA842129B (en)	1983-04-20	1984-03-22	Amino acid-containing fat emulsion
EP19840901610 EP0144434A4 (en)	1983-04-20	1984-04-18	FAT EMULSION CONTAINING AN AMINO ACID.
CA000452321A CA1217725A (en)	1983-04-20	1984-04-18	Amino acid-containing fat emulsion
PCT/JP1984/000196 WO1984004244A1 (fr)	1983-04-20	1984-04-18	Emulsion grasse contenant un acide amine
IT20670/84A IT1176120B (it)	1983-04-20	1984-04-20	Emulsione di grassi contenente amminoacidi
KR1019840002093A KR910002637B1 (ko)	1983-04-20	1984-04-20	아미노산 함유지방유제의 지방미립자화 방법

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP58069712A JPS59193814A (ja)	1983-04-20	1983-04-20	アミノ酸含有脂肪乳剤

Publications (2)

Publication Number	Publication Date
JPS59193814A true JPS59193814A (ja)	1984-11-02
JPH0463049B2 JPH0463049B2 (2)	1992-10-08

Family

ID=13410717

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP58069712A Granted JPS59193814A (ja)	1983-04-20	1983-04-20	アミノ酸含有脂肪乳剤

Country Status (7)

Country	Link
EP (1)	EP0144434A4 (2)
JP (1)	JPS59193814A (2)
KR (1)	KR910002637B1 (2)
CA (1)	CA1217725A (2)
IT (1)	IT1176120B (2)
WO (1)	WO1984004244A1 (2)
ZA (1)	ZA842129B (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993006834A1 (en) *	1991-10-07	1993-04-15	Otsuka Pharmaceutical Factory, Inc.	Enteral preparation for cancer therapy
KR100459025B1 (ko) *	2002-05-02	2004-12-03	(주) 에프디엘	프로포폴을 함유하는 신규한 주사제용 조성물

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6217A (ja) *	1985-02-14	1987-01-06	Chugai Pharmaceut Co Ltd	安定な活性型ビタミンｄ３類製剤
IL78929A0 (en) *	1985-07-29	1986-09-30	Abbott Lab	Microemulsion compositions for parenteral administration
SE8505047L (sv) *	1985-10-25	1987-04-26	Nutritional Int Res Inst	Fettemulsion
US5684050A (en) *	1986-01-24	1997-11-04	Hemagen/Pfc	Stable emulsions of highly fluorinated organic compounds
US5514720A (en) *	1986-07-09	1996-05-07	Hemagen/Pfc	Stable emulsions of highly fluorinated organic compounds
IL88076A (en) *	1987-10-28	1993-01-14	Nippon Shinyaku Co Ltd	Fat emulsions as drug carriers
JP2643217B2 (ja) *	1988-01-22	1997-08-20	エーザイ株式会社	脂溶性物質水性液
US5171755A (en) *	1988-04-29	1992-12-15	Hemagen/Pfc	Emulsions of highly fluorinated organic compounds
US5403575A (en) *	1991-12-12	1995-04-04	Hemagen/Pfc	Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
DE69929128T2 (de)	1998-08-31	2006-06-29	Nipro Corp.	Nährstoffinfusionspräparat
DE102009034115A1 (de) *	2009-07-20	2011-01-27	Beiersdorf Ag	Kosmetische Zubereitung mit einem Gehalt an Acylarginaten

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2850387A (en) *	1955-01-27	1958-09-02	Schwarz Lab Inc	Alpha-amino acid derivative and fats and oils containing same
DE1792034A1 (de) *	1964-09-28	1971-10-07	Yamanouchi Pharma Co Ltd	Verwendung von Glutathion-Aminosaeure-Gemischen als Leberschutzmittel fuer Mensch und Tier
FR6475M (2) *	1967-05-31	1968-11-18
DE1792294B1 (de) *	1968-08-16	1970-07-09	Braun Fa B	Verfahren zur Herstellung stabiler,nicht pyrogener,intravenoes applizierbarer,waessriger aminosaeurehaltiger Fettemulsionen
DE2111361B2 (de) *	1971-03-10	1973-02-15		Verwendung von n-acylaminosaeuren, deren salzen und/oder estern als emulgatoren
JPS5810365B2 (ja) *	1978-09-08	1983-02-25	田辺製薬株式会社	脂肪乳剤
US4499067A (en) *	1982-08-26	1985-02-12	Johnson & Johnson Products, Inc.	Oral compositions comprising NG -acyl derivatives of arginine

1983
- 1983-04-20 JP JP58069712A patent/JPS59193814A/ja active Granted
1984
- 1984-03-22 ZA ZA842129A patent/ZA842129B/xx unknown
- 1984-04-18 EP EP19840901610 patent/EP0144434A4/en not_active Withdrawn
- 1984-04-18 WO PCT/JP1984/000196 patent/WO1984004244A1/ja not_active Ceased
- 1984-04-18 CA CA000452321A patent/CA1217725A/en not_active Expired
- 1984-04-20 KR KR1019840002093A patent/KR910002637B1/ko not_active Expired
- 1984-04-20 IT IT20670/84A patent/IT1176120B/it active

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993006834A1 (en) *	1991-10-07	1993-04-15	Otsuka Pharmaceutical Factory, Inc.	Enteral preparation for cancer therapy
KR100459025B1 (ko) *	2002-05-02	2004-12-03	(주) 에프디엘	프로포폴을 함유하는 신규한 주사제용 조성물

Also Published As

Publication number	Publication date
KR910002637B1 (ko)	1991-04-27
WO1984004244A1 (fr)	1984-11-08
JPH0463049B2 (2)	1992-10-08
CA1217725A (en)	1987-02-10
IT1176120B (it)	1987-08-12
IT8420670A1 (it)	1985-10-20
EP0144434A1 (en)	1985-06-19
IT8420670A0 (it)	1984-04-20
EP0144434A4 (en)	1985-09-02
ZA842129B (en)	1984-10-31
KR840008279A (ko)	1984-12-14

Publication	Publication Date	Title
Shafrir et al.	1960	Role of the pituitary and the adrenal in the mobilization of free fatty acids and lipoproteins
Ririe et al.	2000	Vasodilatory actions of the dietary peptide carnosine
Farris et al.	1998	Effect of tryptophan and of glucose on exercise capacity of horses
Moley et al.	1985	Insulin reversal of cancer cachexia in rats
Clark Jr et al.	1973	Perfluorocarbons having a short dwell time in the liver
Cheng et al.	2016	Intra-articular injection of Torin 1 reduces degeneration of articular cartilage in a rabbit osteoarthritis model
Huai et al.	2012	Melatonin attenuates acute pancreatitis-associated lung injury in rats by modulating interleukin 22
US9289698B2 (en)	2016-03-22	Method for producing extracts from materials and device for realizing same
Xu et al.	2024	Role of polyphenols conjugation to glycated myofibrillar protein in manipulating the emulsifying behaviors of flaxseed oil emulsion
Wang et al.	2025	Enhancement of foaming performance of hempseed protein by limited enzymatic hydrolysis: From the viewpoint of the structural and interfacial rheological attributes
Cooke et al.	1986	Growth and differentiation of fetal rat intestine transplants: dependence on insulin and growth hormone
KR910002637B1 (ko)	1991-04-27	아미노산 함유지방유제의 지방미립자화 방법
Vogt	1951	The role of hypoglycaemia and of adrenaline in the response of the adrenal cortex to insulin
Green et al.	1962	Some acidic substances in neoplastic mast cells and in the pineal body
Khaliulin et al.	2004	Apomorphine prevents myocardial ischemia/reperfusion-induced oxidative stress in the rat heart
Bereiter et al.	1990	Thermal nociception potentiates the release of ACTH and norepinephrine by blood loss
Martemyanov et al.	2018	Regulation of volumes of the muscle, liver, and brain erythrocytes in crucian carp Carassius auratus (Cyprinidae) in response to increase in the osmotic concentration in blood plasma
Schroeder	1942	The effect of a preparation of amine oxidase on experimental hypertension
Duda et al.	1993	Perioperative nonspecific histamine release: a new classification by aetiological mechanisms and evaluation of their clinical relevance
CN106561968A (zh)	2017-04-19	一种在水中可稳定混悬的蛋黄蛋白质粉产品及其制备方法
Hidayat et al.	2016	Protein profile and mda spermatozoa levels of hyperglycemic mice fed by bean sprouts extract
US2032544A (en)	1936-03-03	Anti-anemia material and method of making the same
RU2275205C2 (ru)	2006-04-27	Биологически активный комплекс, содержащий фосфолипиды, для лечения псориаза и хронического простатита
Golin et al.	1991	Effect of head-up tilt on vasopressin secretion and arterial pressure in anesthetized rats
de Graaf et al.	1983	The influence of intravenous hyperalimentation (IVH) on wound healing in tumor‐bearing rats

JPS59193814A - アミノ酸含有脂肪乳剤 - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (7)

Applications Claiming Priority (1)

Publications (2)

Family

ID=13410717

Family Applications (1)

Country Status (7)

Cited By (2)

Families Citing this family (11)

Family Cites Families (7)

Cited By (2)

Also Published As

Similar Documents